Vigabatrine en es it fr

Vigabatrine Brand names, Vigabatrine Analogs

Vigabatrine Brand Names Mixture

  • No information avaliable

Vigabatrine Chemical_Formula

C6H11NO2

Vigabatrine RX_link

No information avaliable

Vigabatrine fda sheet

Vigabatrine msds (material safety sheet)

Vigabatrine Synthesis Reference

No information avaliable

Vigabatrine Molecular Weight

129.157 g/mol

Vigabatrine Melting Point

No information avaliable

Vigabatrine H2O Solubility

55.1 mg/mL

Vigabatrine State

Solid

Vigabatrine LogP

0.056

Vigabatrine Dosage Forms

Powder (500 mg sachets); Tablet (500 mg)

Vigabatrine Indication

For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.

Vigabatrine Pharmacology

Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.

Vigabatrine Absorption

Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.

Vigabatrine side effects and Toxicity

No information avaliable

Vigabatrine Patient Information

This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.

Vigabatrine Organisms Affected

Humans and other mammals